Is Hofseth BioCare ASA (HOFBF) a Buy, Sell, or Hold?
OTC : HOFBF
Hofseth BioCare ASA
$0.1666 USD
$0 (0.0%)
- Volume
- 67.5K
- Average Volume
- 57.75K
- Market Capitalization
- $68.47M
- P/E Ratio
- -4.14
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.18
- Year Low
- $0.17
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.52
Company Overview
OTC
Jon Olav Odegard
Biotechnology
Consumer Defensive
HOFBF
84
NO
USD
Liquidity Metrics
-3.19
0.52
0.29
0.19
0.00
Sales & Valuation
$254.29M
2.37
-5.19
-9.13
-0.15
Profitability
-$0.33
-$134.8M
-56.87%
-56.79%
261.29%
-37.46%
P/E Metrics
-4.14
0.41
0.41
Analyst Price Target & Rating
2/5
0 Analysts
%
Financial Health Scores
-0.38
1/9
-$125.88M
$371.87M
$484.11M
-$112.98M
Key Metrics (TTM)
$865.18M
3.56
-11.72
0.52
261.29%
-48.31%
-24.65%
-11.24%
-46 days
Company Executives
| Name | Title |
|---|---|
| Paul Bruhn | Head of New Business Development & Director |
| Crawford Linden Alexander Currie | Head of Medical R&D and Director |
| Jon Olav Odegard | Chief Executive Officer |
| Bomi Framroze | Chief Scientific Officer |
| Magnus Havnen | Head of Supply Chain |
| Angelika Florvaag | Chief Quality Officer |
| James Berger | Chief Commercial Officer |
| Tom James | Head of Manufacturing |
Poll Results
No votes yet today — be the first to share your view!
About Hofseth BioCare ASA (OTC:HOFBF) Stock
Hofseth BioCare ASA is a company specializing in the development and supply of premium, marine-derived ingredients for various applications in both human and animal health. Its market presence extends from Norway to an international scale. The company offers a diverse array of products. These include its general Brilliant salmon oil, alongside specialized formulations like OmeGo salmon oil, which is designed to support healthy cholesterol levels and cardiovascular function. ProGo, a rapidly absorbing salmon protein hydrolysate powder, serves as an efficient protein supplement. For bone and joint support, CalGo is a marine calcium powder developed to bolster cartilage function and promote overall joint health. Addressing beauty and wellness needs, CollaGo is a collagen peptide powder aimed ... at enhancing the strength and appearance of hair, skin, and nails. Rounding out their offerings is PetGo, a non-soluble protein for animal applications. Hofseth BioCare employs a multi-faceted distribution strategy, reaching customers through a network of independent distributors, agents, and its dedicated internal sales team. Furthermore, the firm maintains a significant research collaboration with the Stanford University School of Medicine. This partnership involves jointly conducting pre-clinical and clinical studies focused on conditions such as necrotizing enterocolitis and irritable bowel syndrome. Established in 2000, Hofseth BioCare ASA maintains its corporate headquarters in Ålesund, Norway.
Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2026
2026-06-09 15:01:00
The Annual General Meeting of Hofseth BioCare ASA for 2026 will be held at the company's premises at Keiser Wilhelms gate 24, 6003 Ålesund, on 30 June 2026 at 11:00 CEST.
Hofseth BioCare ASA: EXCLUSIVE LICENSE AND SUPPLY AGREEMENT SIGNED FOR PROGO FOR OVER $5M
2026-05-21 19:22:00
Hofseth BioCare ASA (“HBC”) has entered into an Exclusive License and Supply Agreement (the “Agreement”) with Fission Holdings LLC (“Fission”), a US-based affiliate and sales channel operator headquartered in Tulsa, Oklahoma. The Agreement grants Fission exclusive worldwide rights to import, market, distribute, and sell HBC's ProGo® salmon-derived bioactive peptide ingredient within the Affiliate, Network Marketing, and Multi-Level Marketing (MLM) channel.
Frequently Asked Questions
-
What is the current Hofseth BioCare ASA (HOFBF) stock price?
-
Hofseth BioCare ASA(OTC:HOFBF) stock price is $0.1666 in the last trading session. During the trading session, HOFBF stock reached the peak price of $0.176 while $0.1666 was the lowest point it dropped to. The percentage change in HOFBF stock occurred in the recent session was 0.0% while the dollar amount for the price change in HOFBF stock was $0.
-
HOFBF's industry and sector of operation?
-
The OTC listed HOFBF is part of Biotechnology industry that operates in the broader Consumer Defensive sector.
-
Who are the executives of HOFBF?
-
Paul Bruhn | Head of New Business Development & Director
Crawford Linden Alexander Currie | Head of Medical R&D and Director
Jon Olav Odegard | Chief Executive Officer
Bomi Framroze | Chief Scientific Officer
Magnus Havnen | Head of Supply Chain -
How many employees does HOFBF have?
-
Number of HOFBF employees currently stands at 84. HOFBF operates from Keiser Wilhelmsgate 24, Ålesund, MR 6003, NO.
-
Link for HOFBF official website?
-
Official Website of HOFBF is: https://www.hofsethbiocare.com
-
How do I contact HOFBF?
-
HOFBF could be contacted at phone #47 73 10 22 00 and can also be accessed through its website. HOFBF operates from Keiser Wilhelmsgate 24, Ålesund, MR 6003, NO.
-
How many shares of HOFBF are traded daily?
-
The average number of HOFBF shares traded daily for last 3 months was 57.75K.
-
What is the market cap of HOFBF currently?
-
The market value of HOFBF currently stands at $68.47M with its latest stock price at $0.1666